Patents
Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108)
05/2006
05/26/2006WO2006002361A3 2-methylpropanamides and their use as pharmaceuticals
05/26/2006CA2588776A1 Substituted amino carboxylic acids
05/26/2006CA2587566A1 Heterocyclylbiphenyl derivates as protein tyrosine phosphatase inhibitors
05/26/2006CA2587511A1 Substituted [(phenylethanoyl)amino] benzamides and the use thereof in the treatment of inflammatory and cardio-vascular diseases
05/25/2006US20060111575 Non-routine reactor shutdown method
05/25/2006US20060111438 Asymmetric synthesis of substituted dihydrobenzofurans
05/25/2006US20060111420 Sorbicillactone-a derivatives for the treatment of tumour and viral diseases
05/25/2006US20060111304 For therapy of pancreatitus, bilioecholic, gastroesophical relux (GERD), irritable bowel syndrome (IBS), non ulcerous dyspepsia
05/25/2006US20060111270 Ketocampholenic acid derivatives and their use in fragrance applications
05/24/2006EP1658263A1 Novel aminobenzophenone compounds
05/24/2006EP1406888B1 Substituted y-lactone compounds serving as nmda antagonists
05/24/2006EP1362462B1 A method and system for a low-overhead mobility management protocol in the internet protocol layer
05/24/2006EP1303580B1 Method for producing marine oils with reduced levels of contaminants
05/24/2006DE102004029812A1 Verfahren zur Herstellung von Nitrilen aus Aldehydoximen durch Umsetzung mit Alkylphosphonsäureanhydriden A process for the production of nitriles from Aldehydoximen by reaction with alkylphosphonic
05/24/2006CN1777577A Antibacterial agents
05/24/2006CN1775770A Method for preparing gibberellin GA4
05/24/2006CN1775769A Method for synthesizing gibberellin GA4
05/24/2006CN1775768A Simple method for preparing gibberellin GA1
05/24/2006CN1775763A Carboxyl acylamide compound and its preparing method and use
05/24/2006CN1257156C Process for the preparation of thiophenols
05/24/2006CN1257153C Novel propargylether derivatives
05/23/2006US7049468 Method for modulating the activity of a Rho C enzyme, comprising: contacting said Rho C enzyme with an effective amount of a compound of formula 1:
05/23/2006US7049459 Chemical intermediate for rofecoxib, cyclooxygenase inhibitor
05/23/2006US7049449 Method for the preparation of lariciresinol cyclolariciresinol and secoisolariciresinol
05/23/2006US7049445 for treating or preventing diabetes, obesity, hyperlipidemia, digestive diseases, depression or urinary disturbances; beta 3-agonist
05/23/2006US7049378 Polymerization of olefin
05/23/2006US7049338 Antiproliferative agents
05/23/2006US7049329 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists
05/23/2006US7049300 C-glycoside compounds for stimulating the synthesis of glycosaminoglycans
05/23/2006CA2356188C Method for the preparation of 5-cyanophthalide
05/23/2006CA2291134C Method for the preparation of citalopram
05/23/2006CA2232141C Substituted tetracyclic tetrahydrofuran derivatives
05/23/2006CA2158454C Taxanes having furyl or thienyl substituted side-chain
05/18/2006WO2006050998A1 5-substituted quinoline and isoquinoline derivatives, a method for the production thereof and their use as antiphlogistics
05/18/2006US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type
05/18/2006US20060106102 Napththalene derivatives which inhibit the cytokine or biological activity of microphage migration inhibitory factor (mif)
05/18/2006US20060106098 Andrographolide and its derivatives as TNF-alpha antagonists
05/18/2006US20060106096 6-[(Anilinocarbonyl)amino]-N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]-1-benzothiophene-2-carboxamide hydrochloride; treatment of dementia, attention deficit hyperactivity disorder and impairments of learning and memory
05/18/2006US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors
05/18/2006US20060106067 Androgen receptor agonist; prostate cancer, hypogonadism; 4-[4-(hydroxymethyl)-1-piperidinyl]-1-naphthonitrile; 4-(4-hydroxy-2-methyl-1-pyrrolidinyl-1-benzothiophene-7-carbonitrile
05/18/2006US20060106053 Therapy of adenocarcinoma of the colon and rectum
05/18/2006US20060106030 N-(4-(4-(2,3 -dichlorophenyl)piperazin-1-yl)but-2-enyl)-1H-indole-2-carboxamide; imaging agents; tomography;diagnosis/medical/; selective, oral bioavailable drugs; nervous system disorders; central nervous system;oral administration; substance abuse ( cocaine/amphetamine); psychosis; Parkinson's
05/18/2006US20060101583 Heating dihydrofuran or dihydropyran derivative in presence of polyglycerol, water, and acid catalysis; deesterification, deamidation; distillation, filtration; aldol condensation; preserving products, for example cosmetic products, and surfaces
05/17/2006EP1656348A1 Acetylene derivatives as inhibitors of histone deacetylase
05/17/2006EP1656144A2 Trp-p8 active compounds and therapeutic treatment methods
05/17/2006EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity
05/17/2006EP1567530B1 Single pot conversion of artemisinin into arteether
05/17/2006EP1551821B1 3-(cyclopenten-1-yl)-benzyl- or 3-(cyclopenten-1-yl)-heteroarylmethyl-amine derivatives and use thereof as medicines for treating schizophrenia
05/17/2006EP1427715B1 Process for preparing 2,5-diformylfuran from carbohydrates
05/17/2006EP1280555B1 Pharmaceutical composition comprising furosemide and conivaptan for the treatment of congestive heart failure
05/17/2006CN1772749A Fungicides for the control of take-all disease of plants
05/17/2006CN1772745A Prepn process of mofe-til mycophenolate
05/17/2006CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists
05/17/2006CN1256333C Method for synthesizing saturated fatty acid vitamin C ester
05/17/2006CN1256332C Process for preparing ranitidine bismuth citrate or ranitidine bismuth tartrate compositions
05/17/2006CN1256324C Pyrrolidine derivatives as factor Xa inhibitors
05/17/2006CN1256308C Yew genus plant extract and its extraction method and application
05/16/2006US7045642 Labeling using deuterium, tritium with catalyst
05/16/2006US7045640 Method of producing 5-formyl-2-furylboronic acid
05/16/2006US7045625 Asymmetric process for the preparation of diarylethylpiperazines derivatives and novel asymmetric diarylmethylamines as intermediates
05/16/2006US7045551 such as (R)-N-[2-hydroxy-1-(3-morpholin-4-yl-phenyl)-ethyl]-3-phenyl-propionamide; for treatment of migraines, bipolar disorders, epilepsy, acute/chronic pain and anxiety
05/16/2006US7045546 Stabilized derivatives of ascorbic acid-3-phosphate
05/16/2006US7045521 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents
05/16/2006US7045518 Compounds for treatment of AIDS with enzyme inhibitors
05/16/2006US7045267 Resist composition comprising photosensitive polymer having lactone in its backbone
05/11/2006WO2006050212A1 Substituted carboxylic acids
05/11/2006WO2006048551A1 Stereoselective preparation of gamma-lactones
05/11/2006WO2006048550A1 Gamma-undecenolactone, method for the preparation and use thereof for cosmetics and in the form of food additives
05/11/2006WO2006048545A1 Method for acylation of an aromatic compound
05/11/2006WO2005077868A3 Congeneric, chlorinated, brominated and/or iodised, fluorinated aromatic compounds comprising two benzol rings in their basic structure, method for their production and use thereof
05/11/2006US20060100448 Process for the production of Y-methyl-A-methylene-Y-butyrolactone from reaction of levulinic acid and hydrogen in the liquid phase followed by reaction of crude-Y-valerolactone and formaldehyde
05/11/2006US20060100447 Process for the production of y-methyl-a-methylene-y-butyrolactone from reaction of levulinic acid and hydrogen with recycle of unreacted levulinic acid followed by reaction of crude y-valerolactone and formaldehyde, both reactions being carried out in the supercritical or near-critical fluid phase
05/11/2006US20060100261 Furan or thiopene derivative and medicinal use thereof
05/11/2006US20060100250 Biphenyl derivatives and their use as fungicides
05/11/2006US20060099323 Comprises successive steps of controlled dehydration of fresh avocados or of avocados that have undergone preliminary transformations, extraction of oil from dehydrated fruit, heat treatment of oil, concentration of unsaponifiable fraction
05/11/2006US20060099222 Novel mixture and compounds from mycelia of antrodia camphorata and use thereof
05/11/2006DE4338348B4 2,6-Disubstituierte Benzotrifluoride 2,6-Disubstituted benzotrifluorides
05/11/2006CA2586953A1 Gamma-undecenolactone, method for the preparation and use thereof for cosmetics and in the form of food additives
05/11/2006CA2585714A1 Method for acylation of an aromatic compound
05/11/2006CA2585550A1 Substituted carboxylic acids
05/10/2006EP1654247A1 Alkynyl aryl carboxamides
05/10/2006EP1654245A1 Benzofuran derivatives useful for treating hyper-proliferative disorders
05/10/2006EP1654244A1 3-aryl-4-hydroxyfuranone compounds and pharmaceutical and veterinary compositions containing them
05/10/2006EP1654213A1 Matrix metalloproteinase inhibitors
05/10/2006EP1653944A1 Heterocyclic compounds useful as malonyl-coa decarboxylase inhibitors
05/10/2006CN1771240A 3-phenylfuran-2-one derivatives as cox-2 inhibitor
05/10/2006CN1771239A Vitamin d3 lactone derivatives
05/10/2006CN1769318A Polymeric resin compounds and their preparation
05/10/2006CN1769287A Method for producing pyridine derivatives
05/10/2006CN1769262A 2-butyl -3-(4 -[3(dibutylamino) propoxy]benzoyl) -5-nitro -benzofuran hydrochloride and preparation thereof.
05/10/2006CN1255397C Lactone category compound of sweetsop as well as new usage in medicines and its preparing method
05/10/2006CN1255396C Carboxylic acid derivatives having fused rings
05/10/2006CN1255395C Apparatus and process for purifying peach aldehyde by decompressing batch rectifying
05/10/2006CN1255214C Coupled method of preparing catalyst of gamma-butyolactone and usage
05/09/2006US7041846 useful as monomers for polymerization to form base resins for use in micropatterning resist compositions; improved transparency, especially at the exposure wavelength of an excimer laser, and improved dry etching resistance
05/09/2006US7041838 (Meth)acrylate esters, starting alcohols for the preparation thereof, processes for preparing both, polymers of the esters, chemically amplifiable resist compositions, and method for forming patterns
05/09/2006US7041691 E.g., 2-(2,6-Dichloro-4-nitro-phenylsulfanyl)-benzothiazole-5-carboxylic acid methyl ester; modulators of peroxisome proliferator-activated receptors (PPARs) to treat type 11 diabetes and obesity; hypertension, hyperlipidemia, hypercholesterolemia, and hyperlipoproteinemia; antiinflammatory agents
05/09/2006US7041690 Viricides; hepatitis virus infections
05/04/2006WO2006047756A2 Substituted tetracycline compounds
05/04/2006WO2006047504A1 Aromatic amides as inhibitors of c-fms kinase